Impact BioMedical, Inc. (IBO)
0.54
+0.06
(+12.50%)
USD |
NYAM |
Sep 04, 16:00
0.5174
-0.02
(-4.19%)
After-Hours: 20:00
Impact BioMedical SG&A Expense (TTM) : 0.349M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.349M |
| March 31, 2026 | 0.006M |
| December 31, 2025 | 0.024M |
| September 30, 2025 | 0.168M |
| June 30, 2025 | 0.627M |
| March 31, 2025 | 0.644M |
| December 31, 2024 | 0.64M |
| September 30, 2024 | 0.616M |
| June 30, 2024 | 0.178M |
| March 31, 2024 | 0.174M |
| December 31, 2023 | 0.199M |
| September 30, 2023 | 0.095M |
| June 30, 2023 | 0.079M |
| March 31, 2023 | 0.094M |
| Date | Value |
|---|---|
| December 31, 2022 | 0.068M |
| September 30, 2022 | 0.058M |
| June 30, 2022 | 0.0792M |
| March 31, 2022 | 0.0506M |
| December 31, 2021 | 0.042M |
| September 30, 2021 | 0.0398M |
| June 30, 2021 | 0.0156M |
| March 31, 2021 | 0.0204M |
| December 31, 2020 | 0.0173M |
| September 30, 2020 | 0.015M |
| June 30, 2020 | 0.011M |
| March 31, 2020 | 0.0058M |
| September 30, 2019 | 0.0035M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| LENZ Therapeutics, Inc. | 151.57M |
| Enveric Biosciences, Inc. | 6.099M |
| ANI Pharmaceuticals, Inc. | 324.76M |
| Corcept Therapeutics, Inc. | 556.47M |
| Veru, Inc. | 16.05M |